Visit COVID-19 resources

[Skip to Content]

Response to: Comments on ‘Confidence of ophthalmology trainees in the management of posterior capsule rupture and vitreous loss’ – (Eye 31, 661 (April 2017))

Apr 13
2017

Response to: Comments on ‘Confidence of ophthalmology trainees in the management of posterior capsule rupture and vitreous loss’ Eye 31, 661 (April 2017). doi:10.1038/eye.2016.223 Authors: A M J Turnbull & S C Lash

  • 13 April 2017

Response to ‘Toy’ laser macular burns in children: 12-month update – (Eye 31, 662 (April 2017))

Apr 13
2017

Response to ‘Toy’ laser macular burns in children: 12-month update Eye 31, 662 (April 2017). doi:10.1038/eye.2016.247 Authors: E Mc Loone & M O’Neill

  • 13 April 2017

Response to ‘Comment on ‘Toy’ laser macular burns in children: 12-month update’ – (Eye 31, 663 (April 2017))

Apr 13
2017

Response to ‘Comment on ‘Toy’ laser macular burns in children: 12-month update’ Eye 31, 663 (April 2017). doi:10.1038/eye.2016.250 Authors: N Raoof & F Quhill

  • 13 April 2017

One size doesn’t fit all: time to revisit patient-reported outcome measures (PROMs) in paediatric ophthalmology? – (Eye 31, 511 (April 2017))

Apr 13
2017

One size doesn’t fit all: time to revisit patient-reported outcome measures (PROMs) in paediatric ophthalmology? Eye 31, 511 (April 2017). doi:10.1038/eye.2016.316 Authors: V Tadić & J S Rahi

  • 13 April 2017

Primary photodynamic therapy with verteporfin for small pigmented posterior pole choroidal melanoma – (Eye 31, 519 (April 2017))

Apr 13
2017

Primary photodynamic therapy with verteporfin for small pigmented posterior pole choroidal melanoma Eye 31, 519 (April 2017). doi:10.1038/eye.2017.22 Authors: I D Fabian, A W Stacey, V Papastefanou, L Al Harby, A K Arora, M S Sagoo & V M L Cohen

  • 13 April 2017